Literature DB >> 6994760

A study of the effects of atenolol and propranolol on renal function in patients with essential hypertension.

R Wilkinson, I M Stevens, M Pickering, V Robson, T Hawkins, D N Kerr, J D Harry.   

Abstract

1 The effects of propranolol and atenolol given in random order in a cross-over study to fifteen patients with essential hypertension have been studied. 2 Both drugs were effective in lowering blood pressure and side effects were not markedly different. 3 There was no change in exchangeable sodium or potassium or in total body potassium during treatment with either drug. 4 Ambulant plasma renin activity was reduced by both drugs but the fall in blood pressure was not related to initial plasma renin. 5 Despite equal mean reduction in blood pressure with the two drugs, creatinine clearance fell significantly only during treatment with propranolol. 6 These observations suggest that intra-renal beta 2-adrenoceptors may be of importance in the regulation of renal function.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994760      PMCID: PMC1430025          DOI: 10.1111/j.1365-2125.1980.tb00501.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  26 in total

1.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

2.  Effects of cyclic AMP, sympathomimetic amines, and adrenergic receptor antagonists on renin secretion.

Authors:  N Winer; D S Chokshi; W G Walkenhorst
Journal:  Circ Res       Date:  1971-09       Impact factor: 17.367

3.  Plasma volume changes with long-term beta-adrenergic blockade.

Authors:  R C Tarazi; E D Frohlich; H P Dustan
Journal:  Am Heart J       Date:  1971-12       Impact factor: 4.749

4.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

5.  Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.

Authors:  D J Warren; C P Swainson; N Wright
Journal:  Br Med J       Date:  1974-04-27

6.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.

Authors:  F R Bühler; J H Laragh; L Baer; E D Vaughan; H R Brunner
Journal:  N Engl J Med       Date:  1972-12-14       Impact factor: 91.245

7.  Mechanism of increased sodium reabsorption during propranolol administration.

Authors:  A S Nies; J S McNeil; R W Schrier
Journal:  Circulation       Date:  1971-10       Impact factor: 29.690

8.  Evaluation of practolol in hypertension. Effects on sympathetic nervous system and renin responsiveness.

Authors:  M D Esler; P J Nestel
Journal:  Br Heart J       Date:  1973-05

9.  [Beta-receptors and renal hemodynamics in humans].

Authors:  J Schirmeister; M Decot; W Hallauer; H Willmann
Journal:  Arzneimittelforschung       Date:  1966-07

10.  Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields.

Authors:  W G Nayler; I McInnes; J B Swann; V Carson; T E Lowe
Journal:  Am Heart J       Date:  1967-02       Impact factor: 4.749

View more
  16 in total

Review 1.  Diabetic nephropathy. Its relationship to hypertension and means of pharmacological intervention.

Authors:  T Baba; S Neugebauer; T Watanabe
Journal:  Drugs       Date:  1997-08       Impact factor: 9.546

Review 2.  Influence of antihypertensive therapy on renal function.

Authors:  U Frei; R Schindler; K M Koch
Journal:  Clin Investig       Date:  1992

Review 3.  Required beta blocker profile in the elderly.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1991-01       Impact factor: 3.727

4.  Effects of dilevalol, an R, R-isomer of labetalol, on blood pressure and renal function in patients with mild-to-moderate essential hypertension.

Authors:  T Baba; S Murabayashi; K Aoyagi; T Ishizaki
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 5.  Beta-blockers and renal function.

Authors:  R Wilkinson
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

6.  Acute changes in renal function induced by bisoprolol, a new cardioselective beta-blocking agent.

Authors:  Z Glück; F C Reubi
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

7.  Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Authors:  I G Mackay; A M Macnicol; H J Smith; A D Cumming; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

8.  The effects of selective beta-adrenoceptor antagonists and partial agonist activity on renal function during exercise in normal subjects and those with moderate renal impairment.

Authors:  D Taverner; I G Mackay; K Craig; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

9.  Labetolol in patients with hypertension and varying degrees of renal impairment.

Authors:  E G Breen; M Lombard; A Watson; J A Keogh
Journal:  Ir J Med Sci       Date:  1984-10       Impact factor: 1.568

10.  Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists.

Authors:  N D Bax; M S Lennard; G T Tucker
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.